Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Valeant
Valeant
Page 3 of 12
Health
T. Rowe Price Sues Valeant Over Alleged Fraud
By
Sy Mukherjee
August 18, 2016
Finance
Here’s Why Shares of Valeant are Soaring
By
Lucinda Shen
August 17, 2016
Finance
How Valeant Defies the Warren Buffett School of Investing
By
Jen Wieczner
August 11, 2016
Finance
Valeant Executives May Be Facing Criminal Prosecution
By
Reuters
August 11, 2016
Finance
Bill Ackman Met Big Investors About Valeant at a Private Brainstorming Dinner
By
Reuters
August 10, 2016
Finance
Valeant’s Troubles Aren’t Driving It To Lower Drug Prices
By
Jen Wieczner
August 9, 2016
Health
Valeant’s CEO Says He Is Not Actively Shopping Core Assets
By
Reuters
August 9, 2016
Health
Here’s Why Shares of Valeant Are Jumping
By
Reuters
August 9, 2016
Finance
Widely Loathed Valeant Pharmaceuticals Gets New Top Lawyer and PR Exec
By
Reuters
August 8, 2016
Health
Whistleblower Claims Celgene Colluded With Charities to Drive Profits
By
Sy Mukherjee
August 1, 2016
Health
The FDA Sees a Problem with Valeant’s New Glaucoma Eye Drops
By
Reuters
July 22, 2016
Finance
Investors Pull $600M After Ackman’s Bad Bets
By
Michelle Celarier
July 19, 2016
Finance
Former Valeant CEO Michael Pearson Just Sold About Five Million Shares of the Company
By
Lucinda Shen
July 13, 2016
Finance
Valeant’s Second Largest Investor Just Dumped the Rest of Its Stock
By
Lucinda Shen
July 13, 2016
Health
New Valeant CEO Meets Investors Amid Company Struggles
By
Reuters
June 14, 2016
Most Popular
Economy
America's $38 trillion national debt 'exacerbates generational imbalances' with Gen Z and millennials paying the price,...
By
Eleanor Pringle
Success
Meetings are not work, says Southwest Airlines CEO—and he’s taking action, by blocking his calendar every afternoon...
By
Preston Fore
Success
'I had to take 60 meetings': Jeff Bezos says 'the hardest thing I've ever done' was raising the first million dollars...
By
Dave Smith